Ginkgo Bioworks Holdings, Inc. acquired Proof Diagnostics, Inc. from Arch Venture Partners, L.P., Madrona Venture Group, LLC and Impresa Management LLC.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) acquired Proof Diagnostics, Inc. from Arch Venture Partners, L.P., Madrona Venture Group, LLC and Impresa Management LLC on February 28, 2024.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) completed the acquisition of Proof Diagnostics, Inc. from Arch Venture Partners, L.P., Madrona Venture Group, LLC and Impresa Management LLC on February 28, 2024.